<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Turk J Haematol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Turk J Haematol</journal-id>
      <journal-id journal-id-type="publisher-id">TJH</journal-id>
      <journal-title-group>
        <journal-title>Turkish Journal of Hematology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1300-7777</issn>
      <issn pub-type="epub">1308-5263</issn>
      <publisher>
        <publisher-name>Galenos Publishing</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26376597</article-id>
      <article-id pub-id-type="pmc">4563208</article-id>
      <article-id pub-id-type="doi">10.4274/tjh.2015.0148</article-id>
      <article-id pub-id-type="publisher-id">1516</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Auer Rods in Chronic Myelomonocytic Leukemia Can Change the Diagnosis</article-title>
        <trans-title-group xml:lang="tr">
          <trans-title>Kronik Miyelomonositik L&#xF6;semide Auer &#xC7;ubuklar&#x131; Tan&#x131;y&#x131; De&#x11F;i&#x15F;tirebilir</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Gajendra</surname>
            <given-names>Smeeta</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="corresp" rid="COR1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sahoo</surname>
            <given-names>Ranjit Kumar</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>
Medanta-The Medicity, Department of Pathology and Laboratory Medicine, Haryana, India
</aff>
      <aff id="A2"><label>2</label>
All India Institute of Medical Sciences, Department of Medical Oncology, New Delhi, India
</aff>
      <author-notes>
        <corresp id="COR1">* Address for Correspondence: Medanta-The Medicity, Department of Pathology and Laboratory Medicine, Haryana, India Phone: +90 09013590875 E-mail: <email>drsmeeta@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>1</day>
        <month>8</month>
        <year>2015</year>
      </pub-date>
      <volume>32</volume>
      <issue>3</issue>
      <fpage>278</fpage>
      <lpage>279</lpage>
      <history>
        <date date-type="received">
          <day>7</day>
          <month>4</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>4</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Turkish Journal of Hematology, Published by Galenos Publishing.&#xD;
</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>Auer rod</kwd>
        <kwd>Chronic myelomonocytic leukemia</kwd>
        <kwd>Hematopoietic stem cell transplantation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>TO THE EDITOR</title>
      <p>Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder with overlapping morphological features of myelodysplastic and myeloproliferative disease and a potential risk of transformation to acute myeloid leukemia. Presence of Auer rods in CMML is a rare finding and the presence of an occasional Auer rod gives the diagnosis of CMML-2 in spite of the presence of &lt;5% blasts in peripheral blood/bone marrow [<xref rid="ref1" ref-type="bibr">1</xref>,<xref rid="ref2" ref-type="bibr">2</xref>]. A 39-year-old female, diagnosed outside our facility with Crohn&#x2019;s disease, presented with severe anemia with weakness and fatigue for 1 month. The patient had been treated previously with prednisolone at 1 mg/kg/day. Diarrhea was resolved after 2 weeks of therapy. Steroid dose was reduced and stopped after 4 months. There were no bowel symptoms and the colonoscopy done at our institution was normal. Hemoglobin was 65 g/L, total leukocyte count was 16.4x109/L, and platelet count was 192x109/L. Peripheral blood smear showed 4% blasts and promonocytes, 3% myelocytes and metamyelocytes, 26% monocytes (including abnormal forms) (<xref ref-type="fig" rid="f1">Figures 1A</xref> and <xref ref-type="fig" rid="f1">1B</xref>), and 2 nucleated red blood cells/100 white blood cells. Bone marrow aspirate was hypercellular with dyspoiesis in all 3 lineages with increased monocytic cells (<xref ref-type="fig" rid="f1">Figures 1C</xref> and <xref ref-type="fig" rid="f1">1D</xref>). Erythroid series showed predominantly megaloblastoid erythropoiesis with nuclear budding, multinuclearity, and cytoplasmic vacuolation. Granulocytic series showed myeloid hyperplasia with 15%-20% monocytes, 2% basophils, and 4% blasts, with an occasional blast showing an Auer rod (<xref ref-type="fig" rid="f1">Figure 1C</xref>, arrows). Micromegakaryocytes and megakaryocytes with abnormal lobation and multinucleation were seen. Bone marrow biopsy was hypercellular (100%) with grade 1 reticulin fibrosis. Megakaryocytes were increased in number and showed hypolobation and multinucleation. Conventional cytogenetics showed a normal female karyotype. There was no Philadelphia chromosome or BCR/ABL fusion gene. Overall features were compatible with a diagnosis of CMML type 2. She was started on 3+7 induction chemotherapy using daunorubicin and ara-C. Bone marrow aspirate done on day 28 confirmed morphological complete remission. She underwent HLA-identical allogeneic hematopoietic stem cell transplantation from her elder brother and currently (2 years posttransplant) continues to be disease-free. Auer rods are a hallmark of acute myeloid leukemia but are occasionally seen in myelodysplastic syndrome (refractory anemia with excess blasts type 2) or CMML cases, and rarely in patients with fewer than 5% blasts [<xref rid="ref3" ref-type="bibr">3</xref>,<xref rid="ref4" ref-type="bibr">4</xref>]. According to the World Health Organization 2008 diagnostic criteria, the presence of Auer rods fulfills the criteria for CMML-2 irrespective of the blast count [<xref rid="ref5" ref-type="bibr">5</xref>]. Thus, in CMML, a thorough search for Auer rods should be done for a correct diagnosis as the treatment given for CMML-2 is different from that for CMML-1 and the risk of transformation to acute leukemia is greater. We also want to emphasize that the presence of Auer rods with fewer than 5% blasts is a rare phenomenon that seems to be clinically, morphologically, and cytogenetically heterogeneous, and it could be a valuable finding for early treatment options in patients with CMML-2 if there is a HLA-identical donor.</p>
      <p>
        <bold>Conflict of Interest Statement</bold>
      </p>
      <p>The author of this paper has no conflict of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included in this manuscript.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Patnaik</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Parikh</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Hanson</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Tefferi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review</article-title>
          <source>Br J Haematol</source>
          <year>2014</year>
          <volume>165</volume>
          <fpage>273</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="pmid">24467717</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Shier</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Auer rods in a patient with chronic myelomonocytic leukemia type 2</article-title>
          <source>Blood</source>
          <year>2014</year>
          <volume>124</volume>
          <fpage>3828</fpage>
          <lpage>3828</lpage>
          <pub-id pub-id-type="pmid">25635282</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Willis</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>McKenna</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Coad</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Kroft</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Low blast count myeloid disorders with Auer rods: a clinicopathologic analysis of 9 cases</article-title>
          <source>Am J Clin Pathol</source>
          <year>2005</year>
          <volume>124</volume>
          <fpage>191</fpage>
          <lpage>198</lpage>
          <pub-id pub-id-type="pmid">16040288</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Germing</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Strupp</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kuendgen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Aivado</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Giagounidis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hildebrandt</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Aul</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gattermann</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals</article-title>
          <source>Br J Haematol</source>
          <year>2006</year>
          <volume>132</volume>
          <fpage>162</fpage>
          <lpage>167</lpage>
          <pub-id pub-id-type="pmid">16398650</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="book" publication-format="print">
          <person-group person-group-type="author">
            <name>
              <surname>Orazi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Germing</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Brunning</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Bain</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Thiele J.</surname>
              <given-names/>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>In: Swerdlow</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Campo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Pileri</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Thiele</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Vardiman</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <chapter-title>WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed</chapter-title>
          <source>growth</source>
          <publisher-loc>Lyon, France</publisher-loc>
          <publisher-name>IARC Press</publisher-name>
          <year>2008</year>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <title>A, B) Peripheral blood smear showing presence of abnormal monocytes along with myelocytes and blast (B- inset). C, D) Bone marrow aspirate showing dyspoiesis in all three lineages (C) with an occasional blast showing an Auer rod (C, arrows) with increased monocytic cells (D) (Jenner and Giemsa stain, 1000x).</title>
      </caption>
      <graphic xlink:href="TJH-32-278-g1"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
